Introduction
Herpes Simplex encephalitis (HSE) is the most common cause of sporadic viral encephalitis in the United States. While acyclovir treatment is a highly effective means to control HSV-1 brain infection (Whitley, 2006) ; greater than fifty percent of human patients with HSE develop life altering neurological deficits (Kimberlin, 2007; McGrath et al., 1997) . These neurological deficits are the result of severe brain damage manifesting as reactive astrogliosis and necrosis (Webb et al., 1989) which in human infections manifests with significant vascular changes with neuronal loss during early stages of the disease and the development of astroglial scaring later in the infection (Whitley, 2006) . The volume of glial scarring correlates to the level of neurological impairment, although the origins of HSV-1-mediated neurological damage and scar formation remain unclear.
In the murine model of experimental HSE, which closely resembles the human disease, immune responses to HSV-1 brain infection begins with infiltration of neutrophils and macrophages between 3 and 5 days p.i. T cells infiltrate between 6 and 8 days p.i. and peak between 14 and 16 days p.i. with significant persistence beyond 30 days p.i. (Armien et al., 2010; Marques et al., 2008) . However, viral antigen is undetectable at 15 days p.i. The role of persistent T lymphocytes at this stage of disease is unknown; however the presence of activated immune cells is indicative of ongoing inflammation that facilitates development of damage and resultant neurological deficits (Armien et al., 2010) . Similar studies in the murine model of Japanese encephalitis and experimental autoimmune encephalitis (EAE) have found that CD8(+) T lymphocyte mediated inflammation may be responsible for brain damage and development of long-term sequellae (Steinman, 2001; Wang et al., 2003) .
A small population of endogenous brain cells called neural stem/ progenitor cells (NSCs) play a significant role in adult neurogenesis Neurobiology of Disease 58 (2013) 144-155 
